Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children

• Main Authors: Weerawan Hattasingh (Author), Pornthep Chanthavanich (Author), Chukiat Sirivichayakul (Author), Watcharee Arunsodsai (Author), Surachai Surangsrirat (Author), Termsang Srisuwannaporn (Author), Benjawan Kaewma (Author), Sutee Yoksan (Author), Kriengsak Limkittikul (Author), Junwei Yang (Author), Yu Mao (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Japanese encephalitis is the main cause of viral encephalitis in Asia. In a previous single-arm vaccine trial, an inactivated chromatographically purified Japanese encephalitis Vero cell vaccine (CVI-JE; JEVACTM) was safe and immunogenic in 152 Thai children aged 1-3 years receiving a 2-dose primary...